Have your own idea? Try our Stock Screener
UPDATED Dec 20, 2024
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
530549 | ₹814.40 | -0.2% | 125.3% | ₹70.7b | ₹1,208.00 | PE115.7x | E77.1% | 0% | ||
A170900 | ₩60,100.00 | 4.0% | -8.9% | ₩539.9b | ₩92,000.00 | PB0.8x | E76.3% | 1.1% | ||
CYCC | US$0.32 | -12.1% | -88.4% | US$2.1m | US$1.00 | PS27x | E76.3% | n/a | ||
ORY | €1.53 | -6.5% | -24.6% | €96.6m | €6.27 | PS6.4x | E76.0% | n/a | ||
CBIO | US$7.67 | 18.6% | -8.4% | US$19.4m | n/a | PE-0.4x | E75.6% | n/a | ||
EVT | €8.41 | 1.6% | -60.1% | €1.5b | €11.04 | PS1.9x | E75.5% | n/a | ||
2096 | HK$6.75 | -6.4% | 6.8% | HK$16.8b | HK$8.91 | PS2.5x | E75.4% | 2.5% | ||
SCPX | US$0.34 | 13.2% | -99.5% | US$1.7m | US$5.00 | PB0.05x | E75.2% | n/a | ||
IPA | US$0.40 | -0.8% | -70.4% | US$14.1m | US$5.00 | PB0.6x | E75.1% | n/a | ||
EOLS | US$10.89 | -5.4% | 9.3% | US$688.3m | US$23.43 | PS2.8x | E74.0% | n/a | ||
A068270 | ₩192,500.00 | -0.5% | 3.8% | ₩39.7t | ₩248,809.52 | PE212.1x | E73.8% | 0.3% | ||
AZT | NOK 13.46 | -1.6% | -67.1% | NOK 687.4m | NOK 16.00 | PE148.5x | E73.8% | n/a | ||
TSVT | US$3.14 | -4.0% | -20.3% | US$150.6m | US$6.75 | PS3.6x | E73.6% | n/a | ||
BLFS | US$27.39 | 2.6% | 70.9% | US$1.2b | US$30.20 | PS8.6x | E73.6% | n/a | ||
ZVRA | US$8.49 | 0.1% | 70.8% | US$455.8m | US$20.00 | PS18.5x | E73.5% | n/a | ||
BIOVIC B | SEK 1.74 | -19.4% | -36.8% | SEK 157.0m | SEK 4.60 | PS21.7x | E73.4% | n/a | ||
BGNE | US$176.50 | -1.6% | 0.2% | US$18.6b | US$280.92 | PS5.8x | E73.3% | n/a | ||
MDGL | US$308.44 | 1.3% | 31.2% | US$6.4b | US$373.00 | PS87.6x | E73.2% | n/a | ||
CYP | AU$0.20 | 11.1% | 66.7% | AU$36.1m | n/a | PS15.6x | E72.9% | n/a | ||
IBRX | US$2.62 | -8.7% | -41.0% | US$1.9b | US$14.25 | PS249x | E72.9% | n/a | ||
VRNA | US$42.02 | 1.4% | 139.3% | US$3.4b | US$47.29 | PS611.4x | E72.8% | n/a | ||
BCRX | US$7.57 | 0.5% | 27.4% | US$1.5b | US$14.82 | PS3.8x | E72.8% | n/a | ||
FTRE | US$19.26 | -3.7% | -44.7% | US$1.7b | US$23.29 | PB1.1x | E72.8% | n/a | ||
CELZ | US$2.07 | -5.4% | -56.2% | US$3.5m | US$30.00 | PS329x | E72.7% | n/a |